Trevi Therapeutics
TRVI
TRVI
53 hedge funds and large institutions have $117M invested in Trevi Therapeutics in 2023 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 16 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
8.9% more ownership
Funds ownership: 72.38% → 81.28% (+8.9%)
Holders
53
Holding in Top 10
–
Calls
$47K
Puts
–
Top Buyers
| 1 | +$5.14M | |
| 2 | +$2.07M | |
| 3 | +$1.39M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.27M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$988K |
Top Sellers
| 1 | -$1.21M | |
| 2 | -$353K | |
| 3 | -$157K | |
| 4 |
Millennium Management
New York
|
-$110K |
| 5 |
IAM
Innovis Asset Management
Chicago,
Illinois
|
-$105K |